Recall
FDAHealthJuly 10, 2025

Beckman Coulter, Inc. — Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860

⚠️ Access Thyroglobulin reagent lot 439163 may generate erroneously high patient results. Falsely increased Access Thyroglobulin results may lead a physician to pursue unnecessary diagnostic imaging studies and/or inappropriate therapy adjustments in patients being monitored for residual or recurrent thyroid cancer.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 10, 2025

Worldwide - US Nationwide and the countries of Brazil, Canada, Georgia, Italy, Malaysia, Mexico, Philippines, Spain.

What's affected?

Product
Access Thyroglobulin assay, a simultaneous one-step immunoenzymatic assay, Catalog Number 33860
Lot code
439163

Additional details

UDI-DI: 15099590227173; Lot Number: 439163

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 453 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.